A comparative study of efficacy and tolerability of cetirizine and bilastine in patients of allergic rhinitis: An open-label, randomized, parallel-group study

Bilastine is equally efficacious as cetirizine and a favorable tolerability profile may make it a more tolerable H1-antihistaminic than cetirizine.

Authors

Institutions

Publication Details

Journal
Perspectives in Clinical Research
Published
2025-05-29
DOI
https://doi.org/10.4103/picr.picr_164_24
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comparative study of efficacy and tolerability of cetirizine and bilastine in patients of allergic rhinitis: An open-label, randomized, parallel-group study

Punam Gosavi, Mrunalini Kalikar, Sneha P. Pawar
Perspectives in Clinical Research
Allergic Rhinitis and Sensitization
article

A comparative study of efficacy and tolerability of cetirizine and bilastine in patients of allergic rhinitis: An open-label, randomized, parallel-group study

Punam Gosavi, Mrunalini Kalikar, Sneha P. Pawar
article en

Abstract

Bilastine is equally efficacious as cetirizine and a favorable tolerability profile may make it a more tolerable H1-antihistaminic than cetirizine.

Perspectives in Clinical ResearchVol. 16(4)
Government Medical College (IN)
Openalex Percentile: Top 82%
Allergic Rhinitis and Sensitization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A comparative study of efficacy and tolerability of cetirizine and bilastine in patients of allergic rhinitis: An open-label, randomized, parallel-group study — Punam Gosavi, Mrunalini Kalikar, et al. · Perspectives in Clinical Research (2025) | TGRS Research Map | TGRS